Tuberculosis: burning issues: multidrug resistance and HIV-coinfection. (Q37993974)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Tuberculosis: burning issues: multidrug resistance and HIV-coinfection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

main subject

tuberculosis

0 references

multiple drug resistance

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Khalid Hussain Janbaz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Bashir Ahmad

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Abida Sarwar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Nazish Yaqoob

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Muhammad Irfan Masood

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

language of work or name

English

0 references

publication date

16 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

Critical Reviews in Microbiology

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

267-275

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22421086%20AND%20SRC:MED&resulttype=core&format=json

Rapid screening of MDR-TB using molecular Line Probe Assay is feasible in Uganda

26 January 2020

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Tuberculosis in Africa — Combating an HIV-Driven Crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Drug-resistant tuberculosis: past, present, future

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Natural and acquired macrolide resistance in mycobacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Clinical features, diagnosis, and management of multiple drug-resistant tuberculosis since 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

The emergence of drug-resistant tuberculosis in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Pathogenesis and management of HIV/TB co-infection in Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Resistance to antimicrobial agents: a personal view

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Treatment of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Multidrug-resistant to extensively drug resistant tuberculosis: what is next?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Novel drugs from marine microorganisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Identification of host-dependent survival factors for intracellular Mycobacterium tuberculosis through an siRNA screen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Treatment outcomes and survival based on drug resistance patterns in multidrug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Bacterial multidrug resistance mediated by a homologue of the human multidrug transporter P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Clinical and genotypic characteristics of extensively drug-resistant and multidrug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Beneficial effects of lactic acid bacteria on human beings.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Molecular properties of bacterial multidrug transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Genetic variation in the HR region of the env gene of HIV: A perspective for resistance to HIV fusion inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Multidrug resistance in the world: the present situation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Resistant tuberculosis: a molecular review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Current perspectives on multidrug-resistant bacteria. Epidemiology and control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539

Priorities for the Treatment of Latent Tuberculosis Infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1040841X.2012.664539